50.27
전일 마감가:
$52.02
열려 있는:
$51.94
하루 거래량:
2.60M
Relative Volume:
1.16
시가총액:
$7.88B
수익:
$1.17B
순이익/손실:
$150.71M
주가수익비율:
53.48
EPS:
0.94
순현금흐름:
$245.03M
1주 성능:
-4.47%
1개월 성능:
+0.76%
6개월 성능:
-36.17%
1년 성능:
-33.38%
바이오-테크네 Stock (TECH) Company Profile
명칭
Bio Techne Corp
전화
(612) 379-8854
주소
614 MCKINLEY PL N E, MINNEAPOLIS, MN
TECH을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
TECH
Bio Techne Corp
|
50.27 | 8.25B | 1.17B | 150.71M | 245.03M | 0.94 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
바이오-테크네 Stock (TECH) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-09 | 개시 | TD Cowen | Buy |
2025-05-30 | 개시 | Wells Fargo | Overweight |
2025-04-09 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
2025-03-18 | 개시 | Evercore ISI | Outperform |
2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
2024-02-08 | 개시 | Scotiabank | Sector Outperform |
2024-02-02 | 다운그레이드 | Stifel | Buy → Hold |
2023-12-07 | 개시 | UBS | Buy |
2023-08-28 | 개시 | William Blair | Outperform |
2023-01-10 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
2022-12-14 | 개시 | Deutsche Bank | Buy |
2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
2022-08-25 | 개시 | Credit Suisse | Outperform |
2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
2021-09-15 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
2021-03-08 | 업그레이드 | Stephens | Equal-Weight → Overweight |
2021-02-23 | 업그레이드 | Stifel | Hold → Buy |
2021-01-25 | 재확인 | The Benchmark Company | Buy |
2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
2020-09-30 | 개시 | Atlantic Equities | Overweight |
2020-07-15 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
2020-05-27 | 다운그레이드 | Stifel | Buy → Hold |
2020-05-14 | 개시 | The Benchmark Company | Buy |
2020-01-08 | 재개 | Stephens | Overweight |
2020-01-08 | 개시 | Wells Fargo | Equal Weight |
2020-01-07 | 개시 | Citigroup | Neutral |
2019-11-15 | 개시 | Stifel | Buy |
2019-07-02 | 업그레이드 | Janney | Neutral → Buy |
2019-01-14 | 업그레이드 | Stephens | Equal-Weight → Overweight |
2018-10-31 | 다운그레이드 | Craig Hallum | Buy → Hold |
2018-10-17 | 개시 | Goldman | Neutral |
2018-06-15 | 개시 | Argus | Buy |
2017-07-13 | 개시 | Wells Fargo | Market Perform |
2017-02-09 | 개시 | Citigroup | Buy |
2017-01-18 | 개시 | Deutsche Bank | Buy |
2016-11-10 | 재개 | Leerink Partners | Outperform |
2015-01-21 | 재확인 | Robert W. Baird | Outperform |
2013-09-20 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
모두보기
바이오-테크네 주식(TECH)의 최신 뉴스
Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch
Envestnet Asset Management Inc. Sells 66,478 Shares of Bio-Techne Corp (NASDAQ:TECH) - Defense World
Bio-Techne’s Quarterly Earnings Preview: What You Need to Know - inkl
Bio-Techne Schedules Q4 2025 Earnings Call: Full Fiscal Year Results Coming August 6 - Stock Titan
Bio-Techne’s Quarterly Earnings Preview: What You Need To Know - Barchart.com
Bio-Techne to distribute Spear Bio’s ultrasensitive immunoassays - Yahoo Finance
Bio-Techne Corp (NASDAQ:TECH) Stake Lessened by M&T Bank Corp - Defense World
Analysts Set Bio-Techne Corp (NASDAQ:TECH) Price Target at $70.00 - Defense World
Why Bio Techne Corporation stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser
How Bio Techne Corporation stock performs during market volatilityFree Expert-Led Investment Training - Newser
What makes Bio Techne Corporation stock price move sharplyOptimized Return Investment Picks - Newser
Here’s Headwaters Capital Management’s Investment Thesis for Bio-Techne (TECH) - Yahoo Finance
Spear Bio partners with Bio-Techne to expand ultrasensitive assay access By Investing.com - Investing.com South Africa
Spear Bio partners with Bio-Techne to expand ultrasensitive assay access - Investing.com
Bio-Techne Secures 1000x More Sensitive Biomarker Detection Technology in Major Neuroscience Partnership - Stock Titan
Bio-Techne (TECH) Partners with Spear Bio for Advanced Biomarker Detection | TECH Stock News - GuruFocus
Revolutionary Alzheimer's Biomarker Detection: Bio-Techne's New Platform Achieves 1000x Higher Sensitivity - Stock Titan
Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection - Yahoo Finance
Bio-techne’s technology supports FDA approval of rare skin disorder therapy - Investing.com
Bio-Techne's Simple Western Enables Breakthrough FDA Approval for Rare Skin Disease Gene Therapy - Stock Titan
Teacher Retirement System of Texas Makes New Investment in Bio-Techne Corp (NASDAQ:TECH) - Defense World
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Principal Financial Group Inc. - Defense World
Teacher Retirement System of Texas Acquires New Holdings in Bio-Techne Corp (NASDAQ:TECH) - Defense World
Scotiabank Has Lowered Expectations for Bio-Techne (NASDAQ:TECH) Stock Price - Defense World
Bio-Techne stock price target lowered to $75 by Scotiabank - Investing.com Canada
TD Cowen Begins Coverage on Bio-Techne (NASDAQ:TECH) - Defense World
Minnesota's highest-paid CEOs made 7% more, with highest paid making $59.4M - Star Tribune
Assessing Bio-Techne: Insights From 7 Financial Analysts - Benzinga
Bio-Techne (TECH) Receives Buy Rating with $65 Price Target from TD Cowen | TECH Stock News - GuruFocus
Bio-Techne (TECH): TD Cowen Initiates Coverage with Buy Rating | - GuruFocus
Vontobel Holding Ltd. Decreases Stake in Bio-Techne Corp (NASDAQ:TECH) - Defense World
5 Revealing Analyst Questions From Bio-Techne’s Q1 Earnings Call - Yahoo Finance
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
GAMMA Investing LLC Cuts Stake in Bio-Techne Corp (NASDAQ:TECH) - Defense World
Amalgamated Bank Purchases 222 Shares of Bio-Techne Corp (NASDAQ:TECH) - Defense World
Is There Now An Opportunity In Bio-Techne Corporation (NASDAQ:TECH)? - Yahoo Finance
How To Trade (TECH) - news.stocktradersdaily.com
Janney Montgomery Scott LLC Grows Stake in Bio-Techne Corp (NASDAQ:TECH) - Defense World
Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock - Zacks Investment Research
Bio-Techne stock holds steady as Stifel maintains $60 price target - Investing.com
Is Bio-Techne Stock Underperforming The Nasdaq? - Barchart.com
Major Breakthrough: Bio-Techne and USP Join Forces to Transform Gene Therapy Development Process - Stock Titan
First Week of August 15th Options Trading For Bio-Techne (TECH) - Nasdaq
Bio-Techne (NASDAQ:TECH) stock performance lags Nasdaq Composite in recent years - Kalkine Media
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
How the (TECH) price action is used to our Advantage - news.stocktradersdaily.com
Bio-Techne Director Cashes Out in Significant Stock Sale - TipRanks
Bio-Techne at Goldman Sachs Conference: Strategic Growth Amid Challenges - Investing.com
TECH Q1 Earnings Call: Management Highlights Market Uncertainties and Strategic Mitigation Efforts - Yahoo Finance
Transcript : Bio-Techne Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10 - MarketScreener
Bio-Techne To Present At Goldman Sachs Global Healthcare Conference; Webcast At 10:40 AM ET - Nasdaq
바이오-테크네 (TECH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):